Arovella Therapeutics thanks retiring director David Simmonds for his service
Arovella Therapeutics Ltd (ASX:ALA), a biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell platform to treat cancer has...
Source: proactiveinvestors.com.au